In order to minimize the risk of downtime and guarantee maximum availability, Vetter preferred to rely on brand-name manufacturers for the installed pumps.
Proteins with therapeutic applications are synthesised in the laboratory for pharmaceutical use. Many recombinant DNA-based processes use genetically modified micro-organisms as host cells (bacteria, yeast or mammalian cells) to produce biological products, under defined conditions, that they would not normally create in their natural form.
Producing MFCs needs gentle handling in hygienic and cool conditions. It’s also crucial to avoid cross-contamination between different batches. GEA helps customers to meet these requirements through state-of-the-art separation, fermentation, heat exchange, cooling, drying and refrigeration technology.
Stay in touch with GEA innovations and stories by signing up for news from GEA.Sign up
We are here to help! With just a few details we will be able to respond to your inquiry.Contact us